Clinical implications of unstable DNA repeat sequences

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 3, 1996, Pages 265-271

  Lindblad, K ^a   Schalling, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anticipation; Dynamic mutations; Fragile X; Genome instability; Huntington's disease; Jacobsen's syndrome; Myotonic dystrophy; Neuropsychiatric disease; Repeat expansion; Repeat expansion detection; Spinal and bulbar muscular atrophy; Spinocerebellar ataxia; Trinucleotide expansions

Indexed keywords

REPETITIVE DNA; TRINUCLEOTIDE;

CHILDHOOD; DNA SEQUENCE; EARLY DIAGNOSIS; GENETIC DISORDER; HUMAN; MUTATION; ONSET AGE; PHENOTYPE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW;

EID: 0029962854     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb14011.x     Document Type: Review

References (67)

1. Morel BA. Traite des degenerescences. Paris: JB Baillaire, 1857
2. Mott FW. Hereditary aspects of nervous and mental diseases. BMJ 1910;2:1013-20
3. Mott FW. A lecture on hereditary and insanity. Lancet 1911;1:1251-9
4. Penrose LS. The problem of anticipation in pedigrees of dystrophia myotonica. Ann Eugenois 1948:14;2:125-132
5. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;352:77-9
6. Yu S, Pritchard M, Kremer E, Lynch M, Nancarrow J, Baker E, et al. Fragile X genotype characterized by an unstable region of DNA. Science 1991;252:1179-81
7. Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991;65:905-14
8. Kremer EJ, Yu S, Pritchard M, Nagarajer R, Heintz D, Lynch M, et al. Isolation of a human DNA sequence which spans the fragile X. Am J Hum Genet 1991;49:656-61
9. Aslanidis C, Jansen G, Amemiya C, Shutler G, Mahadevan M, Tsilfidis C, et al. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 1992;355:548-51
10. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H et al. Molecular basis of myolonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808
11. Fu YH, Pizzuti A, Fenwock RG, King J, Raynarayan S, Dunne PW, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256-8
12. Harley HG, Brook JD, Rundle SA, Crow S, Reardon W, Buckler AJ, et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992;355:545-6
13. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-83
14. Orr HT, Chung M, Banfi S, Kwiatkowski TJ, Servadio A, Beaudet AL, et al. Expansion of an unstable trinucleotide (CAG) repeat in spinocerebellar ataxia type 1. Nat Genet 1993;4:221-6
15. Knight S, Flannery AV, Hirst MC, Campbell L, Christodoulou Z, Phelps SR, et al. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell 1993;74:127-34
16. Koide R, Ikeuchi T, Onodera O, Tanaka H, Igarashi S, Endo K, et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet 1994;1:9-13
17. Nagafuchi S, Yanagisawa H, Sato K, Shirayama T, Ohsaki E, Bundo M, et al. Dentatorubral pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet 1994;1:14-8
18. Kawagushi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, et al. CAG expansions in a novel gene for Macado Joseph disease at chromosome 14q32.1. Nat Genet 1994;8:221-8
19. Jones C, Penny L, Mattina S, Yu E, Baker L, Voullaire L, et al. Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature 1995;376:145-9
20. Housman D. Gain of glutamines, gain of function? Nat Genet 1995;10:3-4
21. Riggins GJ, Lokey LK, Chastain JL, Leiner HA, Sherman SL, Wilkinson KD, et al. Human genes containing polymorphic trinucleotide repeals. Nat Genet 1992;2:186-91
22. Lindblad K, Zander C, Hudson T, Schalling M. Detection of ATG, CCT, CTT and TGG trinucleotide repeat expansions in the human genome. Nat Genet 1994;7:124
23. Gustavsson KH, Blomqvist H, Holmgren G. Prevalence of fragile-X syndrome in mentally retarded children in a Swedish county. Am J Med Genet 1986;23:581-8
24. Sherman SL, Jacobs PA, Morton NE, Froster-Iskerius U, Howard-Peebles PN, Nielsen KB, et al. Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet 1985;69:289-99
25. Fu Y-H, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991;67:1047-58
26. Brown WT, Houck GE, Jeziorowska A, Levinson FN, Ding X, Dobkin C, et al. Rapid fragile carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA 993;270(13):1569-75
27. Jacobs PA, Bullman H, Macpherson J, Yonings S, Rooney V, Watson A, et al. Population studies of the fragile X: a molecular approach. J Med Genet 1993;30:454-9
28. Snow K, Doud LK, Hagerman R, Pergolizzi RG, Erster SH, Thibodeau SN. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 1993;53:1217-28
29. Lubs JA Jr. A marker X chromosome. Am J Hum Genet 1969;21:231-44
30. Torchia BS, Call LM, Migeon BR. DNA replication analysis of FMR1, XIST, and factor 8C loci by FISH shows nontranscribed genes replicate late. Am J Hum Genet 1994;55:96-104
31. Sutcliffe JS, Nelson DL, Zang F, Pieretti M, Caskey CT, Saxe D, et al. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet 1992;1:397-400.63
32. Feng Y, Zhang F, Lokey LK, Chastain JL, Lakkis L, Eberhart D, et al. Translational suppression by trinucleolide repeat expansion at FMRI. Science 1995;268:731-7
33. De Boulle K, Verkerk AJ, Reynoers E, Vits L, Hendrickx J, Van Roy B, et al. A point mutation in the FMR1-gene associated with fragile X mental retardation. Nat Genet 1993;3:31-35
34. Parrish JE, Oostra BA, Verkerk AJMH, Richards CS, Reynolds J, Spikes IS, et al. Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat Genet 994;8:229-35
35. Nancarrow JK, Kremer E, Holman K, Eyre H, Dogett NA, Paslier D, et al. Implications of FRA16A structure for the mechanism of chromosomal fragile sites genesis. Science 1994;264:1938-44
36. Jones C, Slijepcevic P, Marsh S, Baker E, Langdon WY, Richards RI, et al. 1994. Physical linkage of the fragile site FRA11B and a Jacobsen syndrome chromosome deletion breakpoint in 11q23.3. Hum Mol Genet 1994;3:2123-30
37. Sutherland GR. Chromosomal fragile sites. Genet Anal Tech Appl 1991;8:161-6
38. Lavedan C, Hofmann-Radvanyi H, Shelbourne P, Rabes JP, Duros C, Savoy D, et al. Myotonic-dystrophy: size and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism. Am J Hum Genet 1993;52:875-83
39. Fu YH, Friedman DL, Richards S, Pearlman JA, Gibbs RA, Pizzuti A, et al. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 1993;260:235-8
40. Sabouri LA, Mehedevan MS, Narang M, Lee DS, Surh LC, Korneluk RG. Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene. Nat Genet 1993;4:233-8
41. Taneja KL, McCurrach M, Schalling M, Housman D, Singer RA. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 1995;128:995-1002
42. Boucher CA, King SK, Carey N, Krahe R, Winchester CL, Rahman S, et al. A novel homeodomain-encoding gene asociated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeal. Hum Mol Genet 1995;4:1919-25
43. Harper PS, Morris M J, Quarrell O, Shaw DJ, Tyler A, Youngman S. Huntington's disease. Philadelphia: Saunders, 1991
44. Martin JB and Gusella FJ. Huntington's disease; pathogenesis and management. N Engl J Med 1986;315:1267-76
45. Telenius H, Kremer HPH, Theilmann J, Andrew SE, Allqvist E, Anvret M, et al. Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent. Am J Hum Genet 1993;2:1535-40
46. Rosenberg RN. Autosomal dominant cerebellar phenotypes: the genotype has settled the issue. Neurology 1995;45:1-5
47. Lima L and Coutinho P. Clinical criteria for diagnosis of Machado-Joseph disease: report of a non-Azorean Portuguese family. Neurology 1980;30:319-22
48. Silveira I, Lopes-Cendes I, Kish S, Maciel P, Caspar C, Coutinho P, et al. Frequency of spinocerebellar ataxia type 1, dentatorubralpallidoluysian atrophy and Machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients. Neurology. In press.
49. Maciel P, Gaspar C, DeStefano AL, Silveira I, Coutinho P, Radvany J, et al. Correlation between CAG repeat length and clinical features in Machado-Joseph disease. Am J Hum Genet 1995;57:54-61
50. Komure O, Sano A, Nishino N, Yamaushi N, Ueno S, Kondon K, et al. DNA analysis in hereditary dentatorubral-pallidoluysian atrophy: correlation between CAG repeat length and the phenotypic variation and the molecular basis of anticipation. Neurology 1995;45:143-9
51. Harding AE, Thomas PK, Baraitser M, Bradbury PG, Morgan-Hughes JA, Ponsford JR. X-linked recessive bulbospinal neuropathy: a report of ten cases. J Neurol & Psychiatry 1982;45:1012-19
52. Berkovitz GD, Brown TR, Migeon CJ. Androgen receptors. Endocr Metab 1983;12:155-73
53. Janne OA, Palvimo JJ, Kallio P, Mehto. Androgen receptor and mechanism of androgen action. Ann Med 1993;25:83-9
54. Servadio A, Koshy B, Armstrong D, Antalffy B, Orr HT, Zoghbi HY. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nat Genet 1995;10:94-8
55. Trottier Y, Devys D, Imbert G, Saudou F, An I, Lutz Y, et al. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat Genet 1995;10:104-10
56. Yazawa I, Nukina N, Hashida H, Goto J, Yamada M, Kanazawa I. Abnormal gene product identified in hereditary dentatorubralpallidoluysian atrophy (DRPLA) brain. Nat Genet 1995;10:99-103
57. Lucotte G, Turpin JC, Riess O, Epplen JT, Siedlaczk I, Loirat F, et al. Confidence intervals for predicted age of onset, given the size of (CAG)n repeat, in Huntington's disease. Hum Genet 1995;95:231-2
58. Jodice C, Malaspina P, Persichetti F, Novelletto A, Sparado M, Giunti P, et al. Effect of trinucleotide repeat length and parental sex on phenotypic variation in spinocerebellar ataxia I. Am J Hum Genet 1994;54:959-65
59. Schalling M, Hudson TJ, Buetow KH, Housman DE. Direct detection of novel expanded trinucleotide repeats in the human genome. Nat Genet 1993;4:135-9
60. Lindblad K, Lunkes A, Maciel P, Stevanin G, Zander C, Klockgether T, et al. Mutation detection in Machado-Joseph disease using Repeat Expansion Detection. Mol Med 1996;January issue
61. Lindblad K, Nylander P-O, De bruyn A, Sourey D, Zander C, Engström C, et al. Detection of expanded CAG repeats in bipolar affective disorder using the repeat expansion detection (RED) method. Neurobiol Dis 1995;2:55-62
62. O'Donovan MC, Guy C, Craddock N, Murphy KC, Cardno AG, Jones LA, et al. Expanded CAG repeats in schizophrenia and bipolar disorder. Nat Genet 1995;10:380-1
63. Morris AG, Gaitonde E, McKenna PJ, Mollon JD and Hunt DM. CAG repeat expansions and schizophrenia: association with disease in females and with earlier age-at-onset. Hum Mol Genet. 1995;4:1957-61
64. Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G, et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 1995;378:403-6
65. Gispert S, Santos N, Damen R, Voit T, Schultz J, Klockgether T, et al. Autosomal dominant familial spastic paraplegia: reduction of the FSP1 candidate region on chromosome 14q to 7cM and locus heterogeneity. Am J Hum Genet 1995;56:183-7
66. Payami H, Bernard S, Larsen K, Kaye J, Nutt J. Genetic anticipation in Parkinson's disease. Neurology 1995;45:135-8
67. Carrero-Valenzuela R, Lindblad K, Payami H, Johnson W, Schalling M, Stenroos Es, et al. No evidence for association of familial Parkinson's disease with CAG repeat expansions. Neurology 1995;45:1760-2